Concepedia

Author

Carolina Sampedro

EuroEspes Biomedical Research Center

Also Known As

C SAMPEDRO, C. Sampedro, Carolina Sampedro, Sampedro, C.

27

Publications

590

Citations

12

H-Index

43

Concepts

All Affiliations

EuroEspes Biomedical Research CenterEVER Neuro Pharma (Austria)Universidad de Granada
CS

About

Carolina Sampedro is an author at EuroEspes Biomedical Research Center specializing in medicine, neurology, and neuroscience.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

6

6

161

2

Health Sciences

2

2

69

3

Social Sciences

2

2

64

4

Public Health

1

1

11

5

Allergy

1

1

11

Carolina Sampedro

×

13

Publications

564

Citations

12

H-Index

YearCitations

A 24‐week, double‐blind, placebo‐controlled study of three dosages of Cerebrolysin in patients with mild to moderate Alzheimer's disease

X.A. Alvarez, R Cacabelos, M. Laredo,

European Journal of Neurology

2006

98

Citicoline protects hippocampal neurons against apoptosis inducedby brain beta-amyloid deposits plus cerebral hypoperfusion in rats

X.A. Alvarez, Carolina Sampedro, Rafael Lozano,

Methods and Findings in Experimental and Clinical Pharmacology

1999

73

Efficacy and safety of Cerebrolysin in moderate to moderately severe Alzheimer’s disease: results of a randomized, double‐blind, controlled trial investigating three dosages of Cerebrolysin

X.A. Alvarez, Ramón Cacabelos, Carolina Sampedro,

European Journal of Neurology

2010

68

Combination Treatment in Alzheimers Disease: Results of a Randomized, Controlled Trial with Cerebrolysin and Donepezil

X.A. Alvarez, Ramón Cacabelos, Carolina Sampedro,

Current Alzheimer Research

2011

62

Cerebrolysin® reduces microglial activation in vivo and in vitro: a potential mechanism of neuroprotection

X. Anton Álvarez, Valter Lombardi, L. Fernández‐Novoa,

2000

59

Positive effects of Cerebrolysin on electroencephalogram slowing, cognition and clinical outcome in patients with postacute traumatic brain injury: an exploratory study

X. Ant n lvarez, Carolina Sampedro, Paula P rez,

International Clinical Psychopharmacology

2003

47

Reductions in qEEG slowing over 1 year and after treatment with Cerebrolysin in patients with moderate–severe traumatic brain injury

X.A. Alvarez, Carolina Sampedro, Jesús Figueroa,

Journal of Neural Transmission

2008

38

Reduced TNF-α and increased IGF-I levels in the serum of Alzheimer's disease patients treated with the neurotrophic agent Cerebrolysin

X.A. Alvarez, Carolina Sampedro, Ramón Cacabelos,

The International Journal of Neuropsychopharmacology

2009

31

Oral Cerebrolysin® enhances brain alpha activity and improves cognitive performance in elderly control subjects

X.A. Alvarez, Valter Lombardi, Lola Corzo,

2000

26

Protective effect of carvedilol on oxidative stress induced by okadaic acid in N1E-115 cells

Isaac Túnez, Juan A. Collado, Marı́a Muñoz,

Pharmacological Research

2006

17

Page 1